Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sapphire Ventures is a leading global venture capital firm specializing primarily in growth-stage enterprise software investments. Founded originally as the corporate venture arm of SAP SE before spinning out independently in 2011—and rebranding to its current name—it manages over $11 billion across multiple funds. The firm's core focus areas are B2B SaaS/software infrastructure but it also invests selectively across fintech, data & analytics/AI platforms—including some health tech startups like Livongo Health—but it is neither a biotech nor pharma company nor directly involved with drug development or clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sapphire Ventures.